Similar articles

• [Cost evaluation in hospital infections of the urinary tract].

  Calamo Specchia FP, Tagliavia F, Bucci R. Calamo Specchia FP, et al. Ann Ig. 1993 Sep-Oct;5(5):331-9. Ann Ig. 1993. PMID: 7516678 Italian. No abstract available.
• An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients.

  Plowman R, Graves N, Esquivel J, Roberts JA. Plowman R, et al. J Hosp Infect. 2001 May;48(1):33-42. doi: 10.1053/jhin.2001.0938. J Hosp Infect. 2001. PMID: 11358469
• [A method to determine hospital costs associated with nosocomial infections].

  Gianino MM, Vallino A, Anselmo E, Minniti D, Abbona F, Mineccia C, Silvaplana P, Zotti CM. Gianino MM, et al. Ann Ig. 2007 Jul-Aug;19(4):381-92. Ann Ig. 2007. PMID: 17937330 Italian.
• Cost-effective management of complicated urinary tract infections.

  Cox CE. Cox CE. Adv Ther. 1995 Jul-Aug;12(4):222-35. Adv Ther. 1995. PMID: 10155350 Review.
• Ciprofloxacin in urinary tract infections.

  Høiby N. Høiby N. Scand J Infect Dis Suppl. 1989;60:54-7. Scand J Infect Dis Suppl. 1989. PMID: 2667108 Review.